Does continuation of oral anticoagulation reduce thromboembolic events in patients after catheter ablation of atrial fibrillation?
Patients after catheter ablation of atrial fibrillation
Continuation of oral anticoagulation (OAC)
Discontinuation or no oral anticoagulation
Thromboembolic (TE) events and intracranial hemorrhage (ICH)hard clinical
Continuing oral anticoagulation after atrial fibrillation ablation provides a net clinical benefit for patients with a CHA2DS2-VASc score ≥ 2, but offers no benefit for those with a score ≤ 1.
Continuation of OAC after CA of AF with CHA2 DS2 VASc ≥ 2 is associated with a significant decreased TE risk and a favorable net clinical benefit in spite of ICH being significantly increased in the ON-OAC group. Continued OAC offers no benefit with CHA2 DS2 VASC ≤ 1.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jorge Romero
Roberto Cerrud‐Rodriguez
Juan Carlos Díaz
Journal of Cardiovascular Electrophysiology
Albert Einstein College of Medicine
Montefiore Medical Center
Texas Cardiac Arrhythmia
Building similarity graph...
Analyzing shared references across papers
Loading...
Romero et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d5721075589c71d767e473 — DOI: https://doi.org/10.1111/jce.14052